133052-52-5

Basic information

• Product Name: 2-butyl-1-{[2'-(2-trityl-2H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-benzimidazole
• Synonyms: 2-butyl-1-{[2'-(2-trityl-2H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-benzimidazole
• CAS NO: 133052-52-5
• Molecular Formula: C₄₄H₃₈N₆
• Molecular Weight: 650.81272
• Mol File: 133052-52-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-butyl-1-{[2'-(2-trityl-2H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-benzimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-butyl-1-{[2'-(2-trityl-2H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-benzimidazole(133052-52-5)
• EPA Substance Registry System: 2-butyl-1-{[2'-(2-trityl-2H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-benzimidazole(133052-52-5)

Safety Data

• Hazardous Substances Data: 133052-52-5(Hazardous Substances Data)

Downstream Products

• 133052-87-6 2-butyl-1-<(2'-1H-tetrazol-5-ylbiphenyl-4-yl)methyl>benzimidazole 

Relevant articles and documents

Benz[4,5]imidazole-containing angiotensin antagonists

The invention concerns novel heterocyclic compounds of the formula I as defined herein and their physiologically acceptable salts, together with pharmaceutical compositions containing them. The heterocyclic compounds antagonize the actions of angiotensin II and are of value in treating diseases or medical conditions such as hypertension and congestive heart failure in warm-blooded animals. The invention further includes processes for the manufacture of the novel compounds and their use in medical treatment.